🌎 Ford Motor Downgraded, Summit Materials Downgraded, Privia Health…

Ratings changes for Checkpoint Therapeutics, SoundHound AI, Five9, Affirm, Privia Health Group, CrowdStrike, Microchip Technology and more…Upgrade to MarketBeat All Access to get early delivery, personalized stock alerts, portfolio monitoring tools, and more. Start Your Free Trial.

Unsubscribe.

VIEW MY PORTFOLIO

DECEMBER 16TH, 2024

This Revolutionary Biotech is Advancing Through Clinical Trials (ad)

A young company may be priced like a start-up, but they’re making big strides. With Phase 2 clinical trials completed and regulatory approval for phase 2b/phase 3 clinical trials, their cutting-edge technology could position them as a biotech disruptor. Now’s your chance to learn more about this rising star.

REVEAL THIS DISRUPTING OPPORTUNITY TODAY!

Today’s Top Stories

3 Companies Leading the Way With Aggressive Stock Buybacks

BY GABRIEL OSORIO-MAZILLI | DECEMBER 16, 2024 08:46 AM

BITCOIN (Ad)

BY AWESOMELY, LLC

Damaged Russian ships spilled an estimated 3,700 tons of oil in Kerch Strait, state media says

BY THE ASSOCIATED PRESS | DECEMBER 16, 2024 08:55 AM

Is It Time to Buy Nuclear Energy Stocks After the Latest Dip?

BY RYAN HASSON | DECEMBER 16, 2024 08:00 AM

2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad)

BY DARWIN

Trump to announce $100B SoftBank investment in the U.S.

BY THE ASSOCIATED PRESS | DECEMBER 16, 2024 08:46 AM

Best Ultra-Value Stocks Set for Long-Term Growth

BY NATHAN REIFF | DECEMBER 16, 2024 07:45 AM

Quick Links

MarketBeat All Access

Missed Nvidia? Buy Elon Musk’s “Silent Partner” (ad)

In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my favorite stocks.

Today, it’s probably the most popular stock in the world.

I believe this Elon Musk “silent partner” could be the next big AI winner.

SO PLEASE CLICK HERE TO SEE THE DETAILS BECAUSE A LOT OF PEOPLE COULD GET RICH.

Your Watchlist

MANAGE YOUR WATCHLIST AND MONITOR YOUR PORTFOLIO

Apple Inc. (AAPL)

(12/16) Apple Is Modestly Overvalued Despite Potential Margin Pressure and Guru Selling(gurufocus.com)
(12/16) Apple Copies Samsung With Foldable iPhone Plan. What That Means for the Stock.(barrons.com)
(12/16) Apple is working on a foldable iPad and iPhone, reports say (businessinsider.com)
(12/16) Lawmakers call on Apple, Google to prepare for potential TikTok ban (msn.com)
(12/16) Arlington Partners LLC Has $4.12 Million Position in Apple Inc. (NASDAQ:AAPL)(marketbeat.com)

Amazon.com, Inc. (AMZN)

Amazon.com (NASDAQ:AMZN) had its price target raised by analysts at Jefferies Financial Group Inc. ( ) from $235.00 to $275.00. They now have a “buy” rating on the stock. This represents a 18.8% upside from the current price of $231.50.
Amazon.com (NASDAQ:AMZN) had its “market outperform” rating reaffirmed by analysts at JMP Securities ( ). They now have a $285.00 price target on the stock. This represents a 23.1% upside from the current price of $231.50.
(12/16) Amazon.com’s (AMZN) “Market Outperform” Rating Reiterated at JMP Securities(marketbeat.com)
(12/16) E-Commerce Giant PDD Looks Due For a Big Comeback in 2025 (AMZN)(marketbeat.com)
(12/16) Amazon: AWS May Be Formidable, But Not Invincible (seekingalpha.com)
(12/16) 3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term (fool.com)
(12/16) Tech industry curries favor with Trump, NY Times reports (tipranks.com)

Alphabet Inc. (GOOGL)

Alphabet Inc. (NASDAQ:GOOGL) announced a quarterly dividend on Monday, October 28th. Stockholders of record on Monday, December 9th will be paid a dividend of 0.20 per share by the information services provider on Monday, December 16th. This represents a $0.80 annualized dividend and a dividend yield of 0.42%. The ex-dividend date of this dividend is Monday, December 9th.
Director John L. Hennessy sold 1,500 shares of Alphabet stock in a transaction on Thursday, December 12th. The stock was sold at an average price of $194.22, for a total value of $291,330.00. Following the completion of the transaction, the director now owns 23,324 shares in the company, valued at approximately $4,529,987.28. The trade was a 6.04 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.
(12/16) 3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term (fool.com)
(12/16) Investing in the Future of Quantum Computing: Stocks to Watch Now (GOOGL)(marketbeat.com)
(12/16) Alphabet Inc. (NASDAQ:GOOGL) Position Boosted by Tenere Capital LLC(marketbeat.com)
(12/15) 1 Red Flag and 1 Green Flag for Alphabet in 2025 (fool.com)
(12/15) The Trouble With Searching Google for ‘the Best’ (wsj.com)

Meta Platforms, Inc. (META)

Meta Platforms, Inc. (NASDAQ:META) declared a quarterly dividend on Thursday, December 5th. Shareholders of record on Monday, December 16th will be paid a dividend of 0.50 per share by the social networking company on Friday, December 27th. This represents a $2.00 dividend on an annualized basis and a yield of 0.32%. The ex-dividend date is Monday, December 16th.
(12/16) Meta Platforms (META) Unveils Groundbreaking AI Research: From Virtual Agents to Video Watermarking (insidermonkey.com)
(12/16) The Best Stocks to Invest $50,000 in Right Now (fool.com)
(12/15) 3 Market-Beating Tech Stocks to Supercharge Your Portfolio in 2025 and Beyond(fool.com)
(12/15) Meta contractor dismissed threats to moderators by Ethiopia rebels: court documents(reuters.com)
(12/15) Meta’s Rally Isn’t Over: Why It Remains A Buy (seekingalpha.com)

Microsoft Co. (MSFT)

(12/16) Microsoft, Amazon, Google among AI software winners for 2025: Jefferies (msn.com)
(12/16) Microsoft Corp (MSFT) Forms New AI Health Team: Mustafa Suleyman Leads Generative AI Innovations (msn.com)
(12/16) Investing in the Future of Quantum Computing: Stocks to Watch Now (MSFT)(marketbeat.com)
(12/16) Microsoft Reinforces Its Interest in Crypto Despite Rejection of Bitcoin Investments(news.bitcoin.com)
(12/16) Microsoft’s Strategic Advantage with OpenAI and Future Prospects (gurufocus.com)

MANAGE YOUR WATCHLIST

Analysts’ Upgrades

Advanced Energy Industries (NASDAQ:AEIS) was upgraded by analysts at Bank of America Co. from a “neutral” rating to a “buy” rating. They now have a $140.00 price target on the stock. This represents a 16.3% upside from the current price of $120.41.

Ambarella (NASDAQ:AMBA) was upgraded by analysts at Bank of America Co. from an “underperform” rating to a “neutral” rating. They now have a $80.00 price target on the stock. This represents a 6.5% upside from the current price of $75.15.

AMETEK (NYSE:AME) was upgraded by analysts at Bank of America Co. from a “neutral” rating to a “buy” rating. They now have a $225.00 price target on the stock, up previously from $195.00. This represents a 18.1% upside from the current price of $190.58.

Banco BBVA Argentina (NYSE:BBAR) was upgraded by analysts at Morgan Stanley from an “underweight” rating to an “overweight” rating. They now have a $27.00 price target on the stock. This represents a 37.1% upside from the current price of $19.69.

Banco Macro (NYSE:BMA) was upgraded by analysts at Morgan Stanley from an “underweight” rating to an “overweight” rating. They now have a $12.50 price target on the stock. This represents a 88.3% downside from the current price of $107.14.

Bristol-Myers Squibb (NYSE:BMY) was upgraded by analysts at Jefferies Financial Group Inc. from a “hold” rating to a “buy” rating. They now have a $70.00 price target on the stock, up previously from $63.00. This represents a 23.8% upside from the current price of $56.52.

Peabody Energy (NYSE:BTU) was upgraded by analysts at BMO Capital Markets from a “market perform” rating to an “outperform” rating. They now have a $26.00 price target on the stock. This represents a 18.8% upside from the current price of $21.89.

CBRE Group (NYSE:CBRE) was upgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating. They now have a $163.00 price target on the stock, up previously from $120.00. This represents a 17.1% upside from the current price of $139.20.

Concentra Group Holdings Parent (NYSE:CON) was upgraded by analysts at Bank of America Co. from a “neutral” rating to a “buy” rating. They now have a $24.00 price target on the stock. This represents a 14.0% upside from the current price of $21.06.

ConocoPhillips (NYSE:COP) was upgraded by analysts at Mizuho from a “neutral” rating to an “outperform” rating. They now have a $134.00 price target on the stock, up previously from $132.00. This represents a 32.7% upside from the current price of $101.00.

Comstock Resources (NYSE:CRK) was upgraded by analysts at Mizuho from an “underperform” rating to a “neutral” rating. They now have a $18.00 price target on the stock, up previously from $10.00. This represents a 8.8% upside from the current price of $16.55.

Denali Therapeutics (NASDAQ:DNLI) was upgraded by analysts at Stifel Nicolaus from a “hold” rating to a “buy” rating. They now have a $37.00 price target on the stock. This represents a 59.6% upside from the current price of $23.19.

Equifax (NYSE:EFX) was upgraded by analysts at BNP Paribas from a “neutral” rating to an “outperform” rating. They now have a $305.00 price target on the stock. This represents a 13.0% upside from the current price of $269.83.

EQT (NYSE:EQT) was upgraded by analysts at Mizuho from a “neutral” rating to an “outperform” rating. They now have a $57.00 price target on the stock, up previously from $48.00. This represents a 25.7% upside from the current price of $45.36.

Edwards Lifesciences (NYSE:EW) was upgraded by analysts at Bank of America Co. from a “neutral” rating to a “buy” rating. They now have a $90.00 price target on the stock, up previously from $82.00. This represents a 21.6% upside from the current price of $74.00.

Grupo Financiero Galicia (NASDAQ:GGAL) was upgraded by analysts at Morgan Stanley from an “underweight” rating to an “overweight” rating. They now have a $92.00 price target on the stock. This represents a 35.1% upside from the current price of $68.10.

Keysight Technologies (NYSE:KEYS) was upgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating. They now have a $200.00 price target on the stock, up previously from $170.00. This represents a 16.5% upside from the current price of $171.68.

LifeStance Health Group (NASDAQ:LFST) was upgraded by analysts at The Goldman Sachs Group, Inc. from a “neutral” rating to a “buy” rating. They now have a $10.00 price target on the stock. This represents a 31.4% upside from the current price of $7.61.

Macy’s (NYSE:M) was upgraded by analysts at Gordon Haskett from a “hold” rating to a “buy” rating. They now have a $20.00 price target on the stock. This represents a 17.7% upside from the current price of $16.99.

NetApp (NASDAQ:NTAP) was upgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating. They now have a $160.00 price target on the stock. This represents a 27.5% upside from the current price of $125.46.

Okta (NASDAQ:OKTA) was upgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating. They now have a $100.00 price target on the stock. This represents a 17.5% upside from the current price of $85.11.

Grupo Supervielle (NYSE:SUPV) was upgraded by analysts at Morgan Stanley from an “underweight” rating to an “overweight” rating. They now have a $19.00 price target on the stock. This represents a 23.6% upside from the current price of $15.37.

AT&T (NYSE:T) was upgraded by analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating. They now have a $28.00 price target on the stock, up previously from $19.00. This represents a 21.2% upside from the current price of $23.11.

Teradyne (NASDAQ:TER) was upgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating. They now have a $158.00 price target on the stock, up previously from $145.00. This represents a 22.2% upside from the current price of $129.32.

Trimble (NASDAQ:TRMB) was upgraded by analysts at Wolfe Research from a “peer perform” rating to an “outperform” rating. They now have a $90.00 price target on the stock. This represents a 20.4% upside from the current price of $74.78.

U.S. Physical Therapy (NYSE:USPH) was upgraded by analysts at Bank of America Co. from a “neutral” rating to a “buy” rating. They now have a $115.00 price target on the stock, up previously from $100.00. This represents a 18.6% upside from the current price of $97.00.

Zymeworks (NYSE:ZYME) was upgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating. They now have a $18.00 price target on the stock. This represents a 31.4% upside from the current price of $13.70.

VIEW MORE UPGRADES

This Crypto Is Set to Explode in December (ad)

It’s a groundbreaking opportunity that could be poised for extraordinary gains.

The catalyst behind this surge is a massive new blockchain development…

YES, I WANT THE #1 CRYPTO NOW

Analysts’ Downgrades

Adient (NYSE:ADNT) was downgraded by analysts at Wells Fargo & Company from an “overweight” rating to an “equal weight” rating. They now have a $20.00 price target on the stock, down previously from $27.00. This represents a 8.2% upside from the current price of $18.48.

Alector (NASDAQ:ALEC) was downgraded by analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating. They now have a $4.00 price target on the stock. This represents a 102.0% upside from the current price of $1.98.

Amer Sports (NYSE:AS) was downgraded by analysts at HSBC Holdings plc from a “buy” rating to a “hold” rating. They now have a $30.00 price target on the stock. This represents a 7.4% upside from the current price of $27.93.

Credicorp (NYSE:BAP) was downgraded by analysts at Bank of America Co. from a “buy” rating to a “neutral” rating. They now have a $208.00 price target on the stock, down previously from $209.00. This represents a 9.4% upside from the current price of $190.18.

Brown-Forman (NYSE:BF.B) was downgraded by analysts at Truist Financial Co. from a “buy” rating to a “hold” rating. They now have a $45.00 price target on the stock, down previously from $50.00. This represents a 1.9% upside from the current price of $44.18.

Biogen (NASDAQ:BIIB) was downgraded by analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating. They now have a $175.00 price target on the stock. This represents a 16.5% upside from the current price of $150.25.

TopBuild (NYSE:BLD) was downgraded by analysts at Evercore ISI from an “outperform” rating to an “inline” rating. They now have a $381.00 price target on the stock, down previously from $443.00. This represents a 10.8% upside from the current price of $344.00.

Banco Santander-Chile (NYSE:BSAC) was downgraded by analysts at Bank of America Co. from a “buy” rating to a “neutral” rating. They now have a $21.00 price target on the stock, down previously from $22.00. This represents a 8.0% upside from the current price of $19.44.

Comcast (NASDAQ:CMCSA) was downgraded by analysts at Morgan Stanley from an “overweight” rating to an “equal weight” rating. They now have a $45.00 price target on the stock, down previously from $48.00. This represents a 13.9% upside from the current price of $39.51.

CNX Resources (NYSE:CNX) was downgraded by analysts at Mizuho from a “neutral” rating to an “underperform” rating. They now have a $38.00 price target on the stock, up previously from $33.00. This represents a 2.3% upside from the current price of $37.15.

Editas Medicine (NASDAQ:EDIT) was downgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “underweight” rating.The current price is $1.54.

Eagle Materials (NYSE:EXP) was downgraded by analysts at Jefferies Financial Group Inc. from a “buy” rating to a “hold” rating. They now have a $310.00 price target on the stock, down previously from $330.00. This represents a 13.6% upside from the current price of $272.96.

Ford Motor (NYSE:F) was downgraded by analysts at Jefferies Financial Group Inc. from a “hold” rating to an “underperform” rating. They now have a $9.00 price target on the stock, down previously from $12.00. This represents a 10.6% downside from the current price of $10.07.

Installed Building Products (NYSE:IBP) was downgraded by analysts at Evercore ISI from an “outperform” rating to an “underperform” rating. They now have a $206.00 price target on the stock, down previously from $238.00. This represents a 3.3% upside from the current price of $199.47.

Keros Therapeutics (NASDAQ:KROS) was downgraded by analysts at Guggenheim from a “buy” rating to a “neutral” rating.The current price is $19.14.

Logitech International (NASDAQ:LOGI) was downgraded by analysts at Bank of America Co. from a “buy” rating to a “neutral” rating. They now have a $92.00 price target on the stock, down previously from $114.00. This represents a 12.5% upside from the current price of $81.80.

Masco (NYSE:MAS) was downgraded by analysts at Jefferies Financial Group Inc. from a “buy” rating to a “hold” rating. They now have a $89.00 price target on the stock, down previously from $96.00. This represents a 13.3% upside from the current price of $78.54.

Microchip Technology (NASDAQ:MCHP) was downgraded by analysts at Bank of America Co. from a “neutral” rating to an “underperform” rating. They now have a $65.00 price target on the stock, down previously from $80.00. This represents a 9.6% upside from the current price of $59.32.

MongoDB (NASDAQ:MDB) was downgraded by analysts at Monness Crespi & Hardt from a “neutral” rating to a “sell” rating. They now have a $220.00 price target on the stock. This represents a 18.0% downside from the current price of $268.24.

Match Group (NASDAQ:MTCH) was downgraded by analysts at New Street Research from a “buy” rating to a “neutral” rating.The current price is $33.00.

Netflix (NASDAQ:NFLX) was downgraded by analysts at Loop Capital from a “buy” rating to a “hold” rating. They now have a $950.00 price target on the stock, up previously from $800.00. This represents a 2.9% upside from the current price of $922.79.

Northern Oil and Gas (NYSE:NOG) was downgraded by analysts at Mizuho from an “outperform” rating to a “neutral” rating. They now have a $47.00 price target on the stock. This represents a 17.5% upside from the current price of $39.99.

Par Pacific (NYSE:PARR) was downgraded by analysts at Mizuho from an “outperform” rating to a “neutral” rating. They now have a $22.00 price target on the stock, down previously from $26.00. This represents a 38.4% upside from the current price of $15.90.

PBF Energy (NYSE:PBF) was downgraded by analysts at Mizuho from a “neutral” rating to an “underperform” rating. They now have a $31.00 price target on the stock, down previously from $33.00. This represents a 10.3% upside from the current price of $28.11.

Robert Half (NYSE:RHI) was downgraded by analysts at BNP Paribas from an “outperform” rating to an “underperform” rating. They now have a $64.00 price target on the stock. This represents a 15.0% downside from the current price of $75.31.

Suncor Energy (NYSE:SU) (TSE:SU) was downgraded by analysts at Morgan Stanley from an “overweight” rating to an “equal weight” rating.The current price is $36.10.

Summit Materials (NYSE:SUM) was downgraded by analysts at Jefferies Financial Group Inc. from a “buy” rating to a “hold” rating. They now have a $52.50 price target on the stock, down previously from $58.00. This represents a 3.3% upside from the current price of $50.80.

Tenet Healthcare (NYSE:THC) was downgraded by analysts at The Goldman Sachs Group, Inc. from a “buy” rating to a “neutral” rating. They now have a $140.00 price target on the stock, down previously from $196.00. This represents a 2.3% upside from the current price of $136.82.

Universal Health Services (NYSE:UHS) was downgraded by analysts at The Goldman Sachs Group, Inc. from a “buy” rating to a “neutral” rating. They now have a $198.00 price target on the stock, down previously from $228.00. This represents a 5.8% upside from the current price of $187.21.

VIEW MORE DOWNGRADES

Did You See Trump’s Bombshell Exec. Order 001? (ad)

Biden broke it… Now Trump is going to fix it.

Starting with “Exec. Order 001.”

I PUT ALL THE DETAILS TOGETHER FOR YOU HERE — BUT PLEASE HURRY.

Analysts’ New Coverage

Addus HomeCare (NASDAQ:ADUS) is now covered by analysts at JMP Securities. They set an “outperform” rating and a $150.00 price target on the stock. This represents a 15.7% upside from the current price of $129.64.

agilon health (NYSE:AGL) is now covered by analysts at Macquarie. They set a “neutral” rating and a $3.00 price target on the stock. This represents a 30.4% upside from the current price of $2.30.

a.k.a. Brands (NYSE:AKA) is now covered by analysts at Lake Street Capital. They set a “buy” rating and a $30.00 price target on the stock. This represents a 42.9% upside from the current price of $21.00.

Akamai Technologies (NASDAQ:AKAM) is now covered by analysts at UBS Group AG. They set a “neutral” rating and a $110.00 price target on the stock. This represents a 10.3% upside from the current price of $99.77.

Benitec Biopharma (NASDAQ:BNTC) is now covered by analysts at HC Wainwright. They set a “buy” rating and a $28.00 price target on the stock. This represents a 133.1% upside from the current price of $12.01.

biote (NASDAQ:BTMD) is now covered by analysts at Craig Hallum. They set a “buy” rating and a $12.00 price target on the stock. This represents a 81.3% upside from the current price of $6.62.

Colliers International Group (NASDAQ:CIGI) (TSE:CIGI) is now covered by analysts at JPMorgan Chase & Co.. They set a “neutral” rating and a $167.00 price target on the stock. This represents a 14.9% upside from the current price of $145.30.

Caledonia Mining (NYSEAMERICAN:CMCL) is now covered by analysts at Maxim Group. They set a “buy” rating and a $17.00 price target on the stock. This represents a 65.4% upside from the current price of $10.28.

ConocoPhillips (NYSE:COP) is now covered by analysts at Morgan Stanley. They set an “overweight” rating and a $128.00 price target on the stock. This represents a 26.7% upside from the current price of $101.00.

Golden Entertainment (NASDAQ:GDEN) is now covered by analysts at Wells Fargo & Company. They set an “overweight” rating and a $38.00 price target on the stock. This represents a 13.9% upside from the current price of $33.37.

Grindr (NYSE:GRND) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “buy” rating and a $20.00 price target on the stock. This represents a 17.9% upside from the current price of $16.97.

Healthcare Services Group (NASDAQ:HCSG) is now covered by analysts at Macquarie. They set a “neutral” rating and a $13.00 price target on the stock. This represents a 7.3% upside from the current price of $12.12.

Monarch Casino & Resort (NASDAQ:MCRI) is now covered by analysts at Wells Fargo & Company. They set an “underweight” rating and a $79.00 price target on the stock. This represents a 7.3% downside from the current price of $85.18.

Pediatrix Medical Group (NYSE:MD) is now covered by analysts at Macquarie. They set an “outperform” rating and a $18.00 price target on the stock. This represents a 25.5% upside from the current price of $14.34.

Privia Health Group (NASDAQ:PRVA) is now covered by analysts at Macquarie. They set an “outperform” rating and a $25.00 price target on the stock. This represents a 17.3% upside from the current price of $21.31.

Surgery Partners (NASDAQ:SGRY) is now covered by analysts at Bank of America Co.. They set a “buy” rating and a $30.00 price target on the stock. This represents a 43.5% upside from the current price of $20.91.

U.S. Physical Therapy (NYSE:USPH) is now covered by analysts at JMP Securities. They set an “outperform” rating and a $113.00 price target on the stock. This represents a 16.5% upside from the current price of $97.00.

Vishay Intertechnology (NYSE:VSH) is now covered by analysts at JPMorgan Chase & Co.. They set a “neutral” rating and a $19.00 price target on the stock. This represents a 2.5% upside from the current price of $18.53.

Waldencast (NASDAQ:WALD) is now covered by analysts at TD Cowen. They set a “hold” rating and a $4.30 price target on the stock. This represents a 7.8% upside from the current price of $3.99.

ProShares UltraPro Short Nasdaq Biotechnology (NASDAQ:ZBIO) is now covered by analysts at HC Wainwright. They set a “buy” rating and a $30.00 price target on the stock. This represents a 236.3% upside from the current price of $8.92.

VIEW MORE NEW COVERAGE

Calendars from MarketBeat

U.S. Analyst Ratings

Corporate Buybacks

Cryptocurrencies

Dividend Declarations

Earnings Announcements

Earnings Conference Calls

Economic Reports

Gap Up/Down Stocks

Insider Trades

Initial Public Offerings (IPOs)

Most Active Stocks

Percentage Gainers/Decliners

Sector Performance

Short Interest

Stock Splits

Unusual Options Volume

Unusual Trading Volume

GET 30 DAYS OF MARKETBEAT ALL ACCESS FREE

Best-in-Class Portfolio Monitoring

View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations

Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Advanced Stock Screeners and Research Tools

Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.

START YOUR 30-DAY FREE TRIAL

Upgrade Your Subscription

Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET.

UPGRADE NOW

Manage Your Watchlist

View and add up to five holdings to your watchlist.

VIEW MY PORTFOLIO

Join Our Facebook Group

Join MarketBeat’s free stock discussion and trading idea group on Facebook.

JOIN NOW

Wrap Up Your Gifts – Last Chance for Free Shipping 🎁

A Merry and Blessed Christmas

RJ Hamster

🌎 Ford Motor Downgraded, Summit Materials Downgraded, Privia Health Group Initiated and more…

🌎 Ford Motor Downgraded, Summit Materials Downgraded, Privia Health…

DECEMBER 16TH, 2024

This Revolutionary Biotech is Advancing Through Clinical Trials (ad)

Today’s Top Stories

3 Companies Leading the Way With Aggressive Stock Buybacks

BITCOIN (Ad)

Damaged Russian ships spilled an estimated 3,700 tons of oil in Kerch Strait, state media says

Is It Time to Buy Nuclear Energy Stocks After the Latest Dip?

2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad)

Trump to announce $100B SoftBank investment in the U.S.

Best Ultra-Value Stocks Set for Long-Term Growth

Quick Links

Missed Nvidia? Buy Elon Musk’s “Silent Partner” (ad)

Your Watchlist

MANAGE YOUR WATCHLIST AND MONITOR YOUR PORTFOLIO

Analysts’ Upgrades

This Crypto Is Set to Explode in December (ad)

Analysts’ Downgrades

Did You See Trump’s Bombshell Exec. Order 001? (ad)

Analysts’ New Coverage

Calendars from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

Like this:

🌎 Ford Motor Downgraded, Summit Materials Downgraded, Privia Health Group Initiated and more…

DECEMBER 16TH, 2024

This Revolutionary Biotech is Advancing Through Clinical Trials (ad)

Today’s Top Stories

Quick Links

Missed Nvidia? Buy Elon Musk’s “Silent Partner” (ad)

Your Watchlist

Analysts’ Upgrades

This Crypto Is Set to Explode in December (ad)

Analysts’ Downgrades

Did You See Trump’s Bombshell Exec. Order 001? (ad)

Analysts’ New Coverage

Calendars from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

Share this:

Like this:

Related articles